Cargando…
Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
We developed a novel lentiviral vector, pseudotyped with the F and HN proteins from Sendai virus (rSIV.F/HN), that produces long-lasting, high-efficiency transduction of the respiratory epithelium. Here we addressed whether this platform technology can secrete sufficient levels of a therapeutic prot...
Autores principales: | Lund-Palau, Helena, Juarez-Molina, Claudia Ivette, Meng, Cuixiang, Bhargava, Anushka, Pilou, Aikaterini, Aziz, Kiran, Clarke, Nora, Atsumi, Naoko, Ashek, Ali, Wilson, Michael R., Takata, Masao, Padley, Simon, Gill, Deborah R., Hyde, Stephen C., Morgan, Cliff, Alton, Eric W.F.W., Griesenbach, Uta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065048/ https://www.ncbi.nlm.nih.gov/pubmed/35573048 http://dx.doi.org/10.1016/j.omtm.2022.04.002 |
Ejemplares similares
-
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
por: Griesenbach, Uta, et al.
Publicado: (2015) -
Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015) -
Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis
por: Hollox, Edward J, et al.
Publicado: (2005) -
Progress in Respiratory Gene Therapy
por: McLachlan, Gerry, et al.
Publicado: (2022) -
Hot topics in biomaterials
por: Alton, Eric W, et al.
Publicado: (2014)